| Title | Date |
|---|
| MS Trial Alert: Investigators Recruiting for Study Comparing Exercise Programs to Improve Depression | Feb 08, 2012 |
| MS Trial Alert: Pain Study Recruiting People with MS Nationwide | Feb 07, 2012 |
| Research Teams Report on 18 Months of Progress from MS Societies’ Initial Studies on CCSVI and MS | Jan 27, 2012 |
| FDA Updates Tysabri Label to Include Lab Test that Helps Identify Person’s Risk of Developing PML | Jan 23, 2012 |
| European Medicines Agency Commences Safety Review of Gilenya | Jan 20, 2012 |
| National MS Society Convenes Summit to Explore Vitamin D Trials to Prevent MS | Jan 17, 2012 |
| MS Trial Alert: Investigators Recruiting for Studies Comparing Ocrelizumab to Rebif® in People with Relapsing MS | Jan 17, 2012 |
| Sam’s Club Fundraiser to Benefit Society | Jan 17, 2012 |
| Study Offers Insight on How Epstein-Barr Virus May Play a Role in MS | Jan 09, 2012 |
| Study Shows Potential of Lab Test to Detect Virus Which Causes PML in People with MS – ongoing study may help identify risk for PML in people treated with natalizumab | Dec 22, 2011 |
| Results from Trial Comparing Teriflunomide and Rebif in Relapsing MS Do Not Meet Primary Goal | Dec 20, 2011 |
| MS Trial Alert: Investigators Recruiting for Study of Ocrelizumab in Primary-Progressive MS | Dec 19, 2011 |
| Fast Forward and Lineagen to Collaborate to Develop Gene and Biomarker-Based Clinical Assays for Multiple Sclerosis | Dec 16, 2011 |
| Possible Safety Issue Being Investigated with Novartis Pill Gilenya | Dec 12, 2011 |
| Researchers confirm link between MS and a gene linked to vitamin D | Dec 09, 2011 |
| Great Strides Moved MS Research Forward in 2011 | Dec 07, 2011 |
| Novel Study of Underlying Disease Processes in Early MS by MS Lesion Project Team, Co-funded by Society’s Promise:2010 Initiative | Dec 07, 2011 |
| Update: Canadian Government Seeks Proposals for Clinical Trial to Treat CCSVI – Society’s funded CCSVI researchers are among those advising the agency on protocol strategies | Dec 01, 2011 |
| Tovaxin® (T cell vaccination) granted fast-track designation by FDA | Nov 29, 2011 |
| Researchers Recruiting African Americans with MS and Family Members Across the U.S. for Genetics Studies – Key to finding cause of MS and better treatments | Nov 28, 2011 |
| Positive Results Announced from Second Phase III Study of Alemtuzumab in MS | Nov 15, 2011 |
| Multiple Sclerosis Emerging Therapies Collaborative - UPDATE | Nov 14, 2011 |
| National MS Society Launches $16 Million in New Research to Stop MS, Restore Function and End MS Forever -- 32 new grants part of the $45.2 million 2012 investment in cutting-edge research | Nov 11, 2011 |
| Global MS Research Efforts Shared at ECTRIMS/ACTRIMS Meeting | Nov 10, 2011 |
| Raleigh America and Bike MS Team Up | Nov 09, 2011 |
| Phase II results published of clinical trial of ocrelizumab in relapsing MS | Oct 31, 2011 |
| Positive results announced from a second Phase III Trial of oral BG-12 in relapsing MS | Oct 26, 2011 |
| Fast Forward and Athersys Enter Collaboration to Support Development of MultiStem to Treat Multiple Sclerosis | Oct 24, 2011 |
| Survey Finds Majority of People with Multiple Sclerosis Report Difficulty Walking or Maintaining Balance | Oct 20, 2011 |
| MS Trial Alert: Recruiting for a Nationwide Study of an Investigational New Treatment for Spasticity | Oct 17, 2011 |
| Researchers Recruiting 5,000 First-Degree Relatives of People with MS for Genetic/Environmental Research Study | Oct 17, 2011 |
| Results of successful phase III trial of oral teriflunomide for relapsing MS – reduced relapses, MRI disease activity, and higher dose reduced disability progression | Oct 05, 2011 |
| National Multiple Sclerosis Society and Millarworld Join Together to Enhance Awareness for MS Through Comic-book and Movie Character Superior | Oct 05, 2011 |
| MS Trial Alert: Investigators Recruiting for Study Comparing Telephone-Delivered Self-Management Programs to Improve MS Symptoms | Sep 21, 2011 |
| What Triggers MS in Kids? Pediatric Network and Other Sites Recruiting for Study of Environmental and Genetic Risk Factors | Sep 09, 2011 |
| Dr. Kenneth P. Johnson, One of the World’s Leading Innovators in MS Research and Treatment Has Died | Sep 08, 2011 |
| Golden Corral Aims to Raise $100,000 in September for Scholarships | Sep 01, 2011 |
| FDA Approves Botox® for Treating Urinary Incontinence in MS and other Neurologic Conditions | Aug 30, 2011 |
| Update: Ohio Stem Cell Study Recruiting People with MS -- Study supported by the CDMRP, thanks in large part to MS activists who helped secure funding | Aug 23, 2011 |
| MS Trial Alert: Investigators Recruiting for Study of Tysabri in Secondary-Progressive MS | Aug 23, 2011 |
| Information from Medtronic about possible battery issues in Synchromed® drug pumps | Aug 15, 2011 |
| Global Consortium Doubles the Number of MS Risk Genes Identified | Aug 10, 2011 |
| Positive Results Announced from Phase 2 Trial of Daclizumab | Aug 10, 2011 |
| Special Announcement: National MS Society Names New President and CEO | Aug 09, 2011 |
| Study of Laquinimod Does Not Meet Primary Endpoint: Initial Results Announced in Press Release | Aug 02, 2011 |
| Progress in Managing MS Symptoms and Other Results Reported at CMSC Annual Meeting | Jul 27, 2011 |
| New Study on Cost Effectiveness of MS Therapies | Jul 20, 2011 |
| FDA issues warning about medications containing oxybutynin | Jul 15, 2011 |
| Research Teams Report First Year’s Progress From MS Societies’ Initial Studies on CCSVI and MS | Jul 14, 2011 |
| MS Trial Alert: Investigators Studying ELND002, Subcutaneous Drug in 125 People with Relapsing MS | Jul 13, 2011 |
| Positive Results Announced from First Phase III Study of Alemtuzumab in MS | Jul 12, 2011 |
| Study: Bone Health is a Concern in Early MS | Jul 12, 2011 |
| Meeting the Needs of People with Primary Progressive MS, Their Families, and the Health Care Community | Jul 08, 2011 |
| Researchers Funded by Promise:2010 Find Possible Regulator of Myelin Repair | Jun 30, 2011 |
| Study Suggests Most Women with MS Have Normal Pregnancies, Deliveries and Birth Outcomes | Jun 30, 2011 |
| Fast Forward and EMD Serono Provide funding of Over $1 Million to Accelerate Early Stage Research in MS | Jun 30, 2011 |
| Vaccinations in MS - UPDATED | Jun 27, 2011 |
| Company Decides Not to Seek Approval of Cladribine for MS | Jun 22, 2011 |
| MS Trial Alert: Drug Study at NIH Recruiting People with Secondary-Progressive MS | Jun 16, 2011 |
| Neurologists Begin to Build Consensus on Managing Pediatric MS and Similar Disorders | Jun 16, 2011 |
| Study of Large Population in Taiwan Finds Increased Risk of Developing MS following an Attack of Herpes Zoster | Jun 16, 2011 |
| MS Trial Alert: Clinical Trial of Sex Hormone Estriol Recruiting Women with MS to Participate - Updated | Jun 10, 2011 |
| Details About 130 Clinical Trials in MS Now Available | Jun 07, 2011 |
| Researchers Pinpoint Novel Gene-Environment Interaction in Cells from People with MS | Jun 02, 2011 |
| Study: No Link Found Between Stress and Development of Multiple Sclerosis | May 31, 2011 |
| People With MS Caught in Medicare “Donut Hole” Finding Critical Relief Under Affordable Care Act in Their Costs For Prescription Medications | May 27, 2011 |
| MS = How Do you Put A Face on a Disease that Affects Each Person Differently? - Find Out on World MS Day, May 25 - More Than 62 Countries Around the Globe Raising Awareness | May 25, 2011 |
| New Study Shows Low Vitamin D Levels in African Americans with MS | May 25, 2011 |
| MS Research Progress Takes Center Stage at American Academy of Neurology’s Annual Meeting | May 05, 2011 |
| MS Trial Alert: Study of Oral Teriflunomide (HMR1726) Added on to Interferon Beta Recruiting People with Relapsing Forms of MS Worldwide | May 03, 2011 |
| New Mouse Studies May Provide New Therapeutic Targets to Stop MS -- Much research needed to translate to human MS | Apr 26, 2011 |
| Positive Results Announced from Phase 3 Study of Oral BG-12 | Apr 14, 2011 |
| Noted Mayo Clinic Neurologist and Researcher Dr. Brian Weinshenker Wins 2011 John Dystel Prize for MS Research | Apr 12, 2011 |
| MS Trial Alert: Investigators in Oregon Recruiting People with Relapsing MS for Study of Effects of Low-fat Diet on MS Disease Activity; Travel Costs Covered | Apr 08, 2011 |
| $17.5 Million in New Research Projects Launched to Stop MS, Restore Function and End it Forever | Apr 01, 2011 |
| Society Awards 2010 Representatives and Senator of the Year and Congressional Staffer of the Year | Mar 24, 2011 |
| Small, Uncontrolled Study Looks at Long-Term Effects of Bone Marrow Stem Cell Transplantation for MS | Mar 24, 2011 |
| Canbex Therapeutics Receives £1.75 million (USD 2.8 million) from the Wellcome Trust for Translational Research to Develop Treatment for Debilitating Muscle Spasms Associated with MS | Mar 23, 2011 |
| Noted MS Researcher Dr. Lawrence Steinman of Stanford University Wins the MSIF’s Charcot Prize | Mar 22, 2011 |
| MS Trial Alert: Sites in 18 States Recruiting for a Trial of Abatacept for People with Relapsing- Remitting MS | Mar 18, 2011 |
| Early Clinical Trial Results and Observational Study Support Further Research of “Probiotic” Parasitic Worm Treatment Approach in MS | Mar 18, 2011 |
| Multiple Sclerosis Awareness Week: 'MS =' How Do You Put a Face on a Disease that Affects Each Person Differently? | Mar 14, 2011 |
| International Panel Revises “McDonald Criteria” for Diagnosing MS | Mar 09, 2011 |
| FDA Sends Letter Stating that the Application to Market Oral Cladribine for MS is Not Ready for Approval -- Outlines Need for Additional Data | Mar 02, 2011 |
